content=["<dl>",
"<dt><a href='#Section0'>Pulmonary arterial hypertension (PAH) associated with left heart diseases (pulmonary venous hypertension)</a></dt>",
"<dd id='Section0'>",
"<p><strong>Sign & Symptoms:</strong> Older patients, male preponderance, usual cardiovascular risk factors (diabetes, hypertension, smoking). Left ventricular gallops and mitral valve murmurs.",
"<br><strong>Test:</strong> Transthoracic echo: left atrial enlargement, left ventricular systolic and/or diastolic dysfunction, mitral valve disease. [35]Right heart catheterisation: elevated pulmonary capillary wedge pressure, transpulmonary gradient &lt;12 mmHg.Left heart catheterisation: coronary disease, elevated left ventricular end-diastolic pressure.</p>",
"</dd>",
"<dt><a href='#Section1'>PAH associated with lung respiratory diseases and/or hypoxia</a></dt>",
"<dd id='Section1'>",
"<p><strong>Sign & Symptoms:</strong> COPD: &gt;40 to 50 years old, history of smoking, chronic cough and sputum production, decreased breath sounds, wheezing.Interstitial lung disease: history of occupational exposures, drug use, smoking, or connective tissue disease; chronic non-productive cough, bibasilar inspiratory crackles, digital clubbing.Sleep-disordered breathing (e.g., obstructive sleep apnoea): loud snoring, excessive daytime sleepiness, morning headaches, obesity, mild elevations in pulmonary artery pressure.Alveolar hypoventilation disorders: obesity-hypoventilation syndrome, neuromuscular disease.",
"<br><strong>Test:</strong> PFTs: obstructive or restrictive defect.ABG: hypoxaemia, hypercapnia.Overnight oximetry: de-saturation, screening for sleep apnoea.Polysomnography: obstructive sleep apnoea.High-resolution chest CT scan: emphysema, interstitial lung disease.</p>",
"</dd>",
"<dt><a href='#Section2'>PAH due to chronic thrombotic and/or embolic disease</a></dt>",
"<dd id='Section2'>",
"<p><strong>Sign & Symptoms:</strong> History of pulmonary embolism; bruits over the lung fields (pulmonary flow murmurs) are present in 30% of cases and they are not present in IPAH. [37]",
"<br><strong>Test:</strong> Ventilation-perfusion lung scintigraphy: one or more segmental-sized or larger unmatched perfusion defects. [35]Pulmonary angiography: vascular webs or band-like narrowings, intimal irregularities, pouch defects, abrupt and angular narrowing, proximal obstruction. [37]</p>",
"</dd>",
"<dt><a href='#Section3'>PAH associated with: connective tissue disease</a></dt>",
"<dd id='Section3'>",
"<p><strong>Sign & Symptoms:</strong> Multi-system organ involvement: skin lesions, arthralgias/arthritis, GORD, Raynaud's phenomenon, oral ulcers, serositis, renal disease, haematological abnormalities, etc.Scleroderma: especially the limited form (CREST syndrome: calcinosis, Raynaud's phenomenon, oesophageal dysmotility, sclerodactily, and telangiectasis) in the absence of interstitial lung disease. Less severe in the diffuse form of scleroderma. [35]Less common in SLE, mixed connective tissue disease, and rheumatoid arthritis.",
"<br><strong>Test:</strong> Antinuclear antibodies &gt;1:80 titre. [35]Anti-centromere antibodies in limited scleroderma. [33]Anti-U3-ribonucleoprotein (RNP) antibodies in diffuse scleroderma.Anticardiolipin antibodies in lupus.Rheumatoid factor.</p>",
"</dd>",
"<dt><a href='#Section4'>PAH associated with: congenital systemic to pulmonary shunts</a></dt>",
"<dd id='Section4'>",
"<p><strong>Sign & Symptoms:</strong> Simple shunts (more common than complex): ventricular septal defect (highest risk, especially if &gt;1 cm), atrial septal defect (especially if &gt;2 cm and sinus venosus type), patent ductus arteriosus, anomalous pulmonary venous return. [4]Complex shunts: truncus arteriosus (almost all patients develop PAH), atrioventricular septal defects. [4]For all defects, risk of PAH is highest if unrepaired. [4]Eisenmenger's physiology: secondary erythrocytosis, iron deficiency, haemoptysis, 'paradoxical' embolisation, brain abscesses. [38]",
"<br><strong>Test:</strong> Contrast echocardiography with agitated saline ('bubble'): best for shunt reversal (right-to-left). [35]Transoesophageal Doppler echocardiography and/or cardiac MRI: [38]  anatomical definition.Right and left heart catheterisation with oxygen saturation measurement. [35]</p>",
"</dd>",
"<dt><a href='#Section5'>PAH associated with: portal hypertension (portopulmonary hypertension)</a></dt>",
"<dd id='Section5'>",
"<p><strong>Sign & Symptoms:</strong> Mean age of presentation is the fifth decade of life; male-to-female ratio of 1.1:1. [39]Signs of underlying liver disease: jaundice, spider telangiectasia lower extremity oedema, ascites.",
"<br><strong>Test:</strong> LFTs: abnormal. [4]Abdominal ultrasound with colour Doppler: liver cirrhosis, increase in the transhepatic venous gradient.Right heart catheterisation: increased gradient between free and occluded (wedged) hepatic vein pressure.</p>",
"</dd>",
"<dt><a href='#Section6'>PAH associated with: HIV infection</a></dt>",
"<dd id='Section6'>",
"<p><strong>Sign & Symptoms:</strong> HIV risk factors.",
"<br><strong>Test:</strong> Positive HIV serology.</p>",
"</dd>",
"<dt><a href='#Section7'>PAH associated with: drugs and toxins</a></dt>",
"<dd id='Section7'>",
"<p><strong>Sign & Symptoms:</strong> Hx of appetite-suppressant use: aminorex, fenfluramine derivatives, [28]  use of methamphetamine. [30]",
"<br><strong>Test:</strong> Abnormal toxicology.</p>",
"</dd>",
"<dt><a href='#Section8'>PAH associated with: other medical disorders</a></dt>",
"<dd id='Section8'>",
"<p><strong>Sign & Symptoms:</strong> Hx of thyroid disease, haemoglobinopathies, myeloproliferative disorders, splenectomy. [4]  [35]",
"<br><strong>Test:</strong> Abnormal TFTs, FBC with platelet count. [4]  [35]</p>",
"</dd>",
"<dt><a href='#Section9'>Pulmonary veno-occlusive disease/pulmonary capillary haemangiomatosis</a></dt>",
"<dd id='Section9'>",
"<p><strong>Sign & Symptoms:</strong> Digital clubbing and/or basilar rales on examination. [4]",
"<br><strong>Test:</strong> More severe hypoxaemia and decreased in diffusing capacity of the lung for carbon monoxide. [4]CT chest: ground-glass opacities with a centrilobular distribution, septal lines, and adenopathy.Elevated numbers of haemosiderin-laden macrophages in bronchoalveolar lavage fluid.</p>",
"</dd>",
"</dl>"].join("\n");